PeptideStack
5.2kquestions
20kanswers
220users

My a GLP-1 receptor agonist vial sat at 4 °C for twenty-eight days — is testing worth it before use?

Asked 17 May 2025Modified 11 months agoViewed 12k times
36

What I have: a GLP-1 receptor agonist · 4 °C · twenty-eight days.

I would rather over-plan the first cycle and simplify later.

I am prepared to do the work if someone can tell me which work matters.

What is the minimum version of this that is still defensible?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
shareeditfollowflag
RC
askedRP_C18105k34817 May 2025

3 Answers

Accepted answer first, then by votes
41

Accepted answer

Twenty-eight days at 4 °C is about 26 refrigerated days of equivalent exposure. 4 °C is the condition the rule of thumb is anchored to, so it is the baseline rather than a multiplier: everything else in this thread is quoted relative to it. At 26 equivalent days a test is more likely to reassure you than to tell you something, which is a legitimate reason to run it and a poor reason to expect a finding. Either way, record the twenty-eight days and the temperature now, while you still know them; an excursion you did not write down is an excursion you cannot interpret later.

The short version: a spent cold pack on arrival is expected, the solid does not mind, and the pack was never going to last twelve days.

Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.

Anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.

Solid-state stability of lyophilised peptides at ambient temperature is documented in formulation studies with residual moisture as the dominant variable.

The caveat is that a warm transit is survivable for a solid and materially different for a solution.

Buy a logger if you actually want to know. Everything else is inference.

shareimprove this answerflag
TM
answered · acceptedtobias_maartens171k3584 Sept 2025
8Small correction: it is the number of cycles rather than the freezer temperature that does the damage. – tess_amankwah 4 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
44

Start with the physical state, because it changes the answer completely and is the first thing to establish.

A pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.

Asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.

Reconstituted material has a genuine cold-chain requirement and it starts the moment water is added.

A liquefied pack is expected. It is not evidence of a problem.

edited 31 Aug 2025 by zainab_mustafa — clarified the distinction between purity and content

shareimprove this answerflag
ZM
answeredzainab_mustafa21k2713 Aug 2025
2I have kept vials both ways for a year and this matches what I saw. – Dr_Malik_Osei 7 months ago
add a comment
30

Answer first: for a lyophilised solid the cold chain matters far less than people believe, and for a solution it matters far more than they act as though it does.

A single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.

More usefully, once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.

A cold pack tells you nothing about the eleven days before the last one.

Lyophilised tolerates the lane. That is the answer for almost every order.

edited 31 Aug 2025 by lane_transit — added the citation requested in comments

shareimprove this answerflag
LT
answeredlane_transit60k472 Aug 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.